Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells: mediation by nuclear factor-kappaB

Scand J Gastroenterol. 2001 Jul;36(7):706-16. doi: 10.1080/003655201300191969.

Abstract

Background: Helicobacter pylori infection might activate nuclear factor-kappaB (NF-kappaB), a transcriptional regulator of inducible expression of inflammatory genes, interleukin-8 (IL-8) and cyclooxygenase-2 (COX-2). We studied the role of NF-kappaB on expression of IL-8 and COX-2 in H. pylori-stimulated AGS gastric epithelial cells by using antisense oligonucleotide (AS ODN) for NF-kappaB subunit p50 and an antioxidant, glutathione (GSH) as well as a NF-kappaB inhibitor, pyrrolidine dithiocarbamate (PDTC).

Methods: AGS cells were treated with p50 AS ODN, GSH or PDTC in the presence of H. pylori. mRNA expression and protein levels for IL-8 and COX-2 were determined by Northern blot analysis and Western blot analysis. Levels of IL-8, 6-keto-prostaglandin F1alpha (6-keto-PGF1alpha) and thromboxane B2 (TXB2) were measured in the medium by enzyme-linked immunosorbent assay. NF-kappaB activation was examined by electrophoretic mobility shift assay.

Results: H. pylori induced a time-dependent expression of mRNA and protein for IL-8 and COX-2 via activation of NF-kappaB and increased the levels of IL-8, 6-keto-PGF1alpha and TXB2, which were inhibited by GSH and PDTC. H. pylori-induced expression of IL-8 and COX-2 was blocked in AGS cells transfected with p50 AS ODN.

Conclusion: NF-kappaB may play a novel role in expression of IL-8 and COX-2 in H. pylori-induced gastric inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / immunology*
  • Adenocarcinoma / microbiology*
  • Adenocarcinoma / pathology
  • Antioxidants / pharmacology
  • Cyclooxygenase 2
  • Drug Evaluation, Preclinical
  • Epithelium
  • Gastric Mucosa / cytology*
  • Gastric Mucosa / immunology*
  • Gastritis / immunology*
  • Gastritis / microbiology*
  • Gastritis / pathology
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Gene Expression Regulation, Neoplastic / immunology*
  • Glutathione / pharmacology
  • Helicobacter Infections / complications*
  • Helicobacter Infections / immunology*
  • Helicobacter Infections / pathology
  • Helicobacter pylori*
  • Humans
  • Immunity, Mucosal
  • Interleukin-8 / analysis
  • Interleukin-8 / physiology*
  • Isoenzymes / analysis
  • Isoenzymes / drug effects*
  • Isoenzymes / physiology*
  • Membrane Proteins
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / drug effects*
  • NF-kappa B / physiology*
  • Oligonucleotides, Antisense / pharmacology
  • Prostaglandin-Endoperoxide Synthases / analysis
  • Prostaglandin-Endoperoxide Synthases / drug effects*
  • Prostaglandin-Endoperoxide Synthases / physiology*
  • Pyrrolidines / pharmacology
  • Stomach Neoplasms / immunology*
  • Stomach Neoplasms / microbiology*
  • Stomach Neoplasms / pathology
  • Thiocarbamates / pharmacology
  • Time Factors
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / physiology
  • Tumor Cells, Cultured

Substances

  • Antioxidants
  • Interleukin-8
  • Isoenzymes
  • Membrane Proteins
  • NF-kappa B
  • Oligonucleotides, Antisense
  • Pyrrolidines
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Glutathione